STAT+: Pharmalittle: Amgen faces $7B IRS back-tax bill and fine; McKinsey exec apologizes for opioid work during hearing

The top executive at McKinsey appeared for the first time before Congress to answer for the consulting firm’s role in fanning the opioid crisis.